Effectiveness of azacitidine in higher-risk myelodysplastic syndromes | Aplastic Anemia and MDS International Foundation

Effectiveness of azacitidine in higher-risk myelodysplastic syndromes

Journal Title: 
Leukemia
Primary Author: 
Dinmohamed AG
Author(s): 
Dinmohamed AG, van Norden Y, van de Loosdrecht AA, Jongen-Lavrencic M
Original Publication Date: 
Friday, May 20, 2016

No abstract available.

Bone Marrow Diseases: